{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:45:53Z","timestamp":1787852753079,"version":"build-2784847793"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.tcm.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T01:57:18Z","timestamp":1641866238000},"page":"204-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["MEF2 in cardiac hypertrophy in response to hypertension"],"prefix":"10.1016","volume":"33","author":[{"given":"James D.","family":"Cornwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9696-8929","authenticated-orcid":false,"given":"John C.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2022.01.002_bib0001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/B978-0-12-381332-9.00030-X","article-title":"Myocyte enhancer factor 2 transcription factors in heart development and disease","volume":"2","author":"Black","year":"2010","journal-title":"Heart Dev Regen"},{"issue":"9","key":"10.1016\/j.tcm.2022.01.002_bib0002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cells9010242","article-title":"Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding","author":"Simmonds","year":"2020","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.tcm.2022.01.002_bib0003","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"issue":"10304","key":"10.1016\/j.tcm.2022.01.002_bib0004","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.tcm.2022.01.002_bib0005","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2022.01.002_bib0006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09059180.00004612","article-title":"Pulmonary hypertension in left heart disease","volume":"21","author":"Guazzi","year":"2012","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.002_bib0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF03086131","article-title":"Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletes","volume":"16","author":"Mihl","year":"2008","journal-title":"Neth Heart J"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0008","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCRESAHA.115.303910","article-title":"A miR-208\u2013Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension","volume":"116","author":"Paulin","year":"2015","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.tcm.2022.01.002_bib0009","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1002\/clc.20533","article-title":"Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy","volume":"33","author":"Hamada","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2022.01.002_bib0010","article-title":"MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure","volume":"51","author":"Pereira","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.002_bib0011","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M108525200","article-title":"The cardiac-specific nuclear \u03b4B isoform of Ca2+\/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.tcm.2022.01.002_bib0012","doi-asserted-by":"crossref","first-page":"15297","DOI":"10.1074\/jbc.M211312200","article-title":"Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A","volume":"278","author":"Cox","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1050-1738(00)00039-6","article-title":"Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology","volume":"10","author":"Han","year":"2000","journal-title":"Trends Cardiovasc Med"},{"issue":"20","key":"10.1016\/j.tcm.2022.01.002_bib0014","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1093\/nar\/26.20.4771","article-title":"Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5\/BMK1","volume":"26","author":"Yang","year":"1998","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.tcm.2022.01.002_bib0015","first-page":"3335","article-title":"Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors","volume":"26","author":"Gregoire","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.tcm.2022.01.002_bib0016","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.107.760488","article-title":"Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300","volume":"118","author":"Wei","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.tcm.2022.01.002_bib0017","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.0000030181.63741.56","article-title":"Angiotensin II\u2013induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense","volume":"106","author":"Kagiyama","year":"2002","journal-title":"Circulation"},{"issue":"42","key":"10.1016\/j.tcm.2022.01.002_bib0018","doi-asserted-by":"crossref","first-page":"18097","DOI":"10.1073\/pnas.1012826107","article-title":"Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy","volume":"107","author":"Konno","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tcm.2022.01.002_bib0019","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/cddiscovery.2015.19","article-title":"Pro-survival function of MEF2 in cardiomyocytes is enhanced by \u03b2-blockers","volume":"1","author":"Hashemi","year":"2015","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.tcm.2022.01.002_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/eurjhf\/hfp165","article-title":"MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload","volume":"12","author":"El Azzousi","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0021","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1253\/jcj.65.353","article-title":"Molecular mechanism of cardiac hypertrophy and development","volume":"65","author":"Komuro","year":"2001","journal-title":"Jpn Circ J"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/biolre\/ioy179","article-title":"Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats","volume":"100","author":"Mishra","year":"2019","journal-title":"Biol Reprod"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0023","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/eurheartj\/eht308.P2362","article-title":"Vitamin D is independently related to left ventricular hypertrophy in hypertensive patients, whereas effect of parathyroid hormone on left ventricular mass is mediated by blood pressure","volume":"34","author":"Stolarz-Skrzypek","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.tcm.2022.01.002_bib0024","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1096\/fj.09-146589","article-title":"Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension","volume":"24","author":"Oishi","year":"2010","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0025","doi-asserted-by":"crossref","first-page":"A4476","DOI":"10.1038\/s41598-017-04762-x","article-title":"Heart failure and MEF2 transcriptome dynamics in response to \u03b2-blockers","volume":"7","author":"Tobin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tcm.2022.01.002_bib0026","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fphys.2020.00735","article-title":"An overview of the role of calcium\/calmodulin-dependent protein kinase in cardiorenal syndrome","volume":"11","author":"Junho","year":"2020","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0027","article-title":"Role of PI3-kinase in angiotensin II-induced cardiac hypertrophy: Class I versus Class III","volume":"12","author":"Zhong","year":"2021","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.tcm.2022.01.002_bib0028","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11626-019-00395-8","article-title":"Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B\/PI3K\/Akt pathway","volume":"55","author":"Wang","year":"2019","journal-title":"In vitro Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0029","first-page":"P1100","article-title":"Targeting GSK3 and associated signaling pathways involved in cancer","volume":"9","author":"Duda","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tcm.2022.01.002_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yjmcc.2012.10.013","article-title":"Cross-talk between glycogen synthase kinase 3\u03b2 (GSK3\u03b2) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle","volume":"54","author":"Dionyssiou","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2022.01.002_bib0031","doi-asserted-by":"crossref","first-page":"C1089","DOI":"10.1152\/ajpcell.00387.2013","article-title":"A positive feedback loop involving Erk5 and Akt turns on mesangial cell proliferation in response to PDGF","volume":"306","author":"Bera","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"issue":"21","key":"10.1016\/j.tcm.2022.01.002_bib0032","doi-asserted-by":"crossref","first-page":"14590","DOI":"10.1074\/jbc.M800264200","article-title":"Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis","volume":"283","author":"Ha","year":"2008","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.tcm.2022.01.002_bib0033","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/nar\/27.13.2646","article-title":"Post-translational control of the MEF2A transcriptional regulatory protein","volume":"27","author":"Ornatsky","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.002_bib0034","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.yjmcc.2012.07.019","article-title":"Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart","volume":"53","author":"Planavila","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1172\/JCI33255","article-title":"The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice","volume":"118","author":"Kim","year":"2007","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0036","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/nm789","article-title":"Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor","volume":"8","author":"Naya","year":"2002","journal-title":"Nat Med"},{"issue":"5371","key":"10.1016\/j.tcm.2022.01.002_bib0037","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1126\/science.276.5317.1404","article-title":"Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C","volume":"276","author":"Lin","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.002_bib0038","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1073\/pnas.261708699","article-title":"Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"40","key":"10.1016\/j.tcm.2022.01.002_bib0039","doi-asserted-by":"crossref","first-page":"24927","DOI":"10.1074\/jbc.271.40.24927","article-title":"MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells","volume":"271","author":"Ornatsky","year":"1996","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.tcm.2022.01.002_bib0040","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1074\/jbc.M510217200","article-title":"Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice","volume":"281","author":"Xu","year":"2006","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.002_bib0041","doi-asserted-by":"crossref","first-page":"e8472","DOI":"10.1371\/journal.pone.0008472","article-title":"MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR\/S6K pathway in mice","volume":"4","author":"Pereira","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI84015","article-title":"RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure","volume":"126","author":"Gao","year":"2016","journal-title":"J Clin Investig"},{"issue":"9","key":"10.1016\/j.tcm.2022.01.002_bib0043","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/MCB.00248-08","article-title":"Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D","volume":"28","author":"Du","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.tcm.2022.01.002_bib0044","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1101\/gad.215400.113","article-title":"Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation","volume":"27","author":"Sebastian","year":"2013","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.002_bib0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/stem.2495","article-title":"Dynamic phosphorylation of the myocyte enhancer factor 2C\u03b11 splice variant promotes skeletal muscle regeneration and hypertrophy","volume":"35","author":"Baruffaldi","year":"2017","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.002_bib0046","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/B:CARD.0000041245.61136.56","article-title":"The mTOR\/p70S6K signal transduction pathway plays a role in cardiac hypertrophprocy and influences expression of myosin heavy chain genes in vivo","volume":"18","author":"Boluyt","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"10.1016\/j.tcm.2022.01.002_bib0047","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2022.01.002_bib0048","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2014\/713894","article-title":"SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy","volume":"2014","author":"Shen","year":"2014","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.002_bib0049","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.105.608968","article-title":"MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-Induced heart failure","volume":"114","author":"van Oort","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0050","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1242\/dev.126.6.1269","article-title":"The cardiac homeobox gene Csx\/Nkx2.5 lies genetically upstream of multiple genes essential for heart development","volume":"126","author":"Tanaka","year":"1999","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.002_bib0051","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/MCB.00832-15","article-title":"A p38 mitogen-activated protein kinase-regulated myocyte enhancer factor 2\u2013\u03b2-catenin interaction enhances canonical Wnt signaling","volume":"36","author":"Ehyai","year":"2016","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.tcm.2022.01.002_bib0052","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice","volume":"119","author":"Callis","year":"2009","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.002_bib0053","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/MCB.00227-08","article-title":"Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1\u03b1 represses MEF2-dependent gene expression","volume":"29","author":"Perry","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0054","doi-asserted-by":"crossref","first-page":"e9127","DOI":"10.15252\/emmm.201809127","article-title":"Nuclear receptor corepressor 1 represses cardiac hypertrophy","volume":"11","author":"Li","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151515","article-title":"miR-410 and miR-495 are dynamically regulated in diverse cardiomyopathies and their inhibition attenuates pathological hypertrophy","volume":"11","author":"Clark","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0056","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13293-019-0223-0","article-title":"Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease","volume":"10","author":"Kessler","year":"2019","journal-title":"Biol Sex Differ"},{"issue":"6","key":"10.1016\/j.tcm.2022.01.002_bib0057","doi-asserted-by":"crossref","first-page":"H2204","DOI":"10.1152\/ajpheart.01219.2005","article-title":"Estrogen receptor-\u03b1 mediates acute myocardial protection in females","volume":"290","author":"Wang","year":"2006","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.002_bib0058","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2005.06.019","article-title":"17-\u03b2-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia","volume":"40","author":"Wang","year":"2006","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0059","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCRESAHA.109.207084","article-title":"Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor","volume":"106","author":"Van Rooij","year":"2010","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.002_bib0060","doi-asserted-by":"crossref","first-page":"e90822","DOI":"10.1371\/journal.pone.0090822","article-title":"Gender-specific potential inhibitory role of Ca2+\/calmodulin dependent protein kinase phosphatase (CaMKP) in pressure-overloaded mouse heart","volume":"9","author":"Previlon","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0061","doi-asserted-by":"crossref","first-page":"A15928","DOI":"10.1038\/s41598-019-52280-9","article-title":"The role of cardiac transcription factor NKX2-5 in regulating the human cardiac miRNAome","volume":"9","author":"Arasaratnam","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.tcm.2022.01.002_bib0062","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.yjmcc.2007.03.499","article-title":"MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure","volume":"42","author":"Thum","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.002_bib0063","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cell.2012.03.029","article-title":"A cardiac microRNA governs systemic energy homeostasis by regulation of MED13","volume":"149","author":"Grueter","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0064","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/JOE-15-0506","article-title":"Supra-physiological dose of testosterone induces pathological cardiac hypertrophy","volume":"229","author":"Pirompol","year":"2016","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.002_bib0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.RES.86.4.386","article-title":"Myosin heavy chain isoform expression in the failing and nonfailing human heart","volume":"86","author":"Miyata","year":"2000","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.002_bib0066","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1152\/ajpheart.2001.280.4.H1814","article-title":"Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles","volume":"280","author":"Reiser","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.tcm.2022.01.002_bib0067","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1152\/physiolgenomics.00163.2011","article-title":"Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure","volume":"44","author":"Reddy","year":"2012","journal-title":"Physiol Genom"},{"key":"10.1016\/j.tcm.2022.01.002_bib0068","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41598-020-58327-6","article-title":"Systematic comparison of high-throughput single-cell and single-nucleus transcriptomes during cardiomyocyte differentiation","volume":"10","author":"Selewa","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0069","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yjmcc.2015.06.020","article-title":"Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy","volume":"86","author":"Dadson","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2022.01.002_bib0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00109-013-1059-4","article-title":"A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension","volume":"91","author":"Sutendra","year":"2013","journal-title":"J Mol Med"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.002_bib0071","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cell.2013.09.007","article-title":"MEF2 is an in vivo immune-metabolic switch","volume":"155","author":"Clark","year":"2013","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.tcm.2022.01.002_bib0072","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1074\/jbc.M117.776153","article-title":"Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors","volume":"292","author":"Desjardins","year":"2017","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1016\/j.tcm.2022.01.002_bib0073","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1128\/MCB.24.18.8264-8275.2004","article-title":"Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity","volume":"24","author":"Zhu","year":"2004","journal-title":"Mol Cell Biol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:02:42Z","timestamp":1760936562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173822000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1050173822000044"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2022.01.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEF2 in cardiac hypertrophy in response to hypertension","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}